✦ LIBER ✦

NGAL: a biomarker of acute kidney injury and other systemic conditions

✍ Scribed by Sachin S. Soni; Dinna Cruz; Ilona Bobek; Chang Yin Chionh; Federico Nalesso; Paolo Lentini; Massimo de Cal; Valentina Corradi; Grazia Virzi; Claudio Ronco

Publisher: Springer Netherlands
Year: 2009
Tongue: English
Weight: 203 KB
Volume: 42
Category: Article
ISSN: 0301-1623
DOI: 10.1007/s11255-009-9608-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Kidney NGAL is a novel early marker of a

Kidney NGAL is a novel early marker of acute injury following transplantation

✍ Jaya Mishra; Qing Ma; Caitlin Kelly; Mark Mitsnefes; Kiyoshi Mori; Jonathan Bara 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 172 KB

Clinical significance of tubular and pod

Clinical significance of tubular and podocyte biomarkers in acute kidney injury

✍ Katsuomi Matsui; Atsuko Kamijo-Ikemori; Masanori Hara; Takeshi Sugaya; Takamitsu 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 385 KB

Biomarkers of acute kidney injury in chi

Biomarkers of acute kidney injury in children: discovery, evaluation, and clinical application

✍ Zubaida Al-Ismaili; Ana Palijan; Michael Zappitelli 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 283 KB

Insufficient performance of serum cystat

Insufficient performance of serum cystatin C as a biomarker for acute kidney injury of postrenal etiology

✍ Julia Hasslacher; Georg F. Lehner; Michael Joannidis 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 190 KB

Hypoalbuminemia and acute kidney injury:

Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies

✍ Christian J. Wiedermann; Wolfgang Wiedermann; Michael Joannidis 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 386 KB

Validation of a novel biomarker for acut

Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis

✍ Melissa M. Gresle; Gerry Shaw; Bevyn Jarrott; Estella N. Alexandrou; Anna Friedh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB

## Abstract In multiple sclerosis, inflammatory axonal injury is a key pathological mechanism responsible for the development of progressive neurological dysfunction. The injured axon represents a therapeutic target in this disease; however, therapeutic trials of neuroprotective candidates will ini